Skip Navigation

VAERS Bibliography - April 2002

  1. Shortage of varicella and measles, mumps and rubella vaccines and interim recommendations from the Advisory Committee on Immunization Practices  MMWR CDC Surveill Summ.  3-8-2002, 51 (9): 190-191.

  2. From the Centers for Disease Control. Status of US Department of Defense preliminary evaluation of the association of anthrax vaccination and congenital anomalies  JAMA.  3-6-2002, 287 (9): 1107.

  3. Time to look beyond MMR in autism research  Lancet.  2-23-2002, 359 (9307): 637.

  4. From the Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage--Advisory Committee on Immunization Practices  JAMA.  2002, %20;287 (7): 833-834.

  5. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). NACI update to statement on varicella vaccine  Can.Commun.Dis.Rep.  2-15-2002, 28:1-7. (): 1-7.

  6. Bibliography. Current world literature. Infectious diseases and immunization  Curr.Opin.Pediatr.  2002, 14 (1): 138-147.

  7. Small improvements seen in patient, staff vaccinations  Nephrol.News Issues.  2002, 16 (3): 18-25.

  8. Barton, L. L.  Immunology series: vaccines  N.Engl.J.Med.  3-14-2002, 346 (11): 864-866.

  9. Bond, L., Davie, G., Carlin, J. B., Lester, R., and Nolan, T.  Increases in vaccination coverage for children in child care, 1997 to 2000: an evaluation of the impact of government incentives and initiatives  Aust.N.Z.J.Public Health.  2002, 26 (1): 58-64.

  10. Bradbury, J.  USA to increase smallpox vaccine stockpile  Lancet Infect.Dis.  2001, 1 (5): 290.

  11. Bradshaw, J. and Wright, P. F.  Cold-adapted influenza vaccines  Curr.Opin.Pediatr.  2002, 14 (1): 95-98.

  12. Burton, A. Spain says good-bye to measles  Lancet Infect.Dis.  2001, 1 (3): 142.

  13. Chan, L., Maclehose, R. F., and Houck, P. M.  Impact of physician reminders on the use of influenza vaccinations: A randomized trial  Arch.Phys.Med.Rehabil.  2002, 83 (3): 371-375.

  14. Cohen, R., Aujard, Y., Bingen, E., Boucherat, M., Bourrillon, A., Foucaud, P., Francois, M., Garnier, J. M., Guillot, M., Ovetchkine, P., Ployet, M. J., Quinet, B., and Gaudelus, J.  [Therapeutic approaches in children immunized with vaccine Prevenar]  Arch.Pediatr.  2002, 9 (1): 4-6.

  15. Diodati, C.  Mandatory vaccination of health care workers  CMAJ.  2-5-2002, 166 (3): 301-302.

  16. Donlin, J.  The influenza vaccine  NCSL.Legisbrief.  2002, 10 (17): 1-2.

  17. Garcia-Doval, I., Roson, E., Feal, C., De la, Torre C., Rodriguez, T., and Cruces, M. J.  Generalized bullous fixed drug eruption after influenza vaccination, simulating bullous pemphigoid  Acta Derm.Venereol.  2001, 81 (6): 450-451.

  18. Georgitis, J. W. and Fasano, M. B.  Allergenic components of vaccines and avoidance of vaccination-related adverse events  Curr.Allergy Rep.  2001, 1 (1): 11-17.

  19. Gold, M. S.  Hypotonic-hyporesponsive episodes following pertussis vaccination: a cause for concern?  Drug Saf.  2002, 25 (2): 85-90.

  20. Grabenstein, J. D., Guess, H. A., Hartzema, A. G., Koch, G. G., and Konrad, T. R.  Attitudinal factors among adult prescription recipients associated with choice of where to be vaccinated  J.Clin.Epidemiol.  2002, 55 (3): 279-284.

  21. Hackley, B. K.  Controversies in immunization practices: vaccine safety and implications for midwifery practice  J.Midwifery Womens Health.  2002, 47 (1): 16-27.

  22. Hahne, S. J., Gray, S. J., Jean, Francois, Aguilera, Crowcroft, N. S., Nichols, T., Kaczmarski, E. B., and Ramsay, M. E.  W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001  Lancet.  2-16-2002, 359 (9306): 582-583.

  23. Howe, M.  Pneumoccocal vaccination programme begins in Australia  Lancet Infect.Dis.  2001, 1 (2): 69.

  24. Hull, H. F.  The future of polio eradication  Lancet Infect.Dis.  2001, 1 (5): 299-303.

  25. Jentoft, H. F., Omenaas, E., Eide, G. E., and Gulsvik, A.  Absence of relationship between tuberculin reactivity and asthmatic symptoms, level of FEV1 and bronchial hyperresponsiveness in BCG vaccinated young adults  Allergy.  2002, 57 (4): 336-340.

  26. Josefson, D.  US encourages flu jabs for infants aged under 2  BMJ.  3-2-2002, 324 (7336): 502.

  27. Klugman, K. P.  Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance  Lancet Infect.Dis.  2001, 1 (2): 85-91.

  28. Kudesia, G., Partridge, S., Farrington, C. P., and Soltanpoor, N.  Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy  J.Clin.Pathol.  2002, 55 (2): 154-155.

  29. Lacson, A. G., D'Cruz, C. A., Gilbert-Barness, E., Sharer, L., Jacinto, S., and Cuenca, R.  Aluminum Phagocytosis in Quadriceps Muscle following Vaccination in Children: Relationship to Macrophagic Myofasciitis  Pediatr.Dev.Pathol.  2002, 5 (2): 151-158.

  30. Levy-Bruhl, D.  [What place for BCG vaccination in France?]  Arch.Pediatr.  2002, 9 (1): 1-3.

  31. Levy-Bruhl, D. and Guerin, N.  The use of smallpox virus as a biological weapon: the vaccination situation in France  Euro.Surveill.  2001, 6 (11): 171-178.

  32. Lista, F., Faggioni, G., Peragallo, M. S., Tontoli, F., Stella, A., Salvatori, P., Pusino, M., Germani, M. A., Contreas, V., and D'Amelio, R.  Molecular analysis of early postvaccine mumps-like disease in Italian military recruits  JAMA.  3-6-2002, 287 (9): 1114-1115.

  33. Meyers, D. G. and Jurisich, P. D.  Could vaccinations prevent myocardial infarction?  Am.J.Cardiol.  3-15-2002, 89 (6): 723-725.

  34. Moreton, J.  MMR vaccination: the case for evidence-based practice  Br.J.Community Nurs.  2001, 6 (4): 199-200.

  35. Obaro, S. and Adegbola, R.  The pneumococcus: carriage, disease and conjugate vaccines  J.Med.Microbiol.  2002, 51 (2): 98-104.

  36. Orellana, C.  Mexican vaccine against typhoid fever in phase I trial  Lancet Infect.Dis.  2001, 1 (5): 292.

  37. Osterholm, M. T.  How to vaccinate 30,000 people in three days: realities of outbreak management  Public Health Rep.  2001, 116 Suppl 2:74-8. (): 74-78.

  38. Paterson, R.  Human trials start for new tuberculosis vaccine  Lancet Infect.Dis.  2001, 1 (5): 291.

  39. Persaude, D., Teape-Humphrey, L., Adelstein, R., Domb, S., and Jaakkimainen, L.  Peril of the pox. Are primary care providers aware of varicella vaccination guidelines?  Can.Fam.Physician.  2002, 48:316-23. (): 316-323.

  40. Peterson, D. C., Bahta, L., and Ehresmann, K.  Vaccinating adults for vaccine-preventable diseases  Minn.Med.  2002, 85 (2): 37-39.

  41. Pollard, A. J. and Scheifele, D.  Meningococcal disease and vaccination in North America  J.Paediatr.Child Health.  2001, 37 (5): S20-S27.

  42. Rehme, P. A., Williams, R., and Grabenstein, J.  Ambulatory medical visits among anthrax-vaccinated and unvaccinated personnel after return from southwest Asia  Mil.Med.  2002, 167 (3): 205-210.

  43. Reinert, P.  The role of pneumococcal and haemophilus type B vaccination in the prevention of acute otitis media  Clin.Microbiol.Infect.  1997, 3 Suppl 3:S59-S61. (): S59-S61.

  44. Rokicka-Milewska, R., Machala, M., Klukowska, A., Laguna, P., and Sikorska-Fic, B.  Efficacy of subunit trivalent influenza vaccine in previously vaccinated children suffering from hemophilia  Clin.Microbiol.Infect.  1998, 4 (10): 589-593.

  45. Rothberg, M., Bennish, M. L., Kao, J. S., and Wong, J. B.  Do the benefits of varicella vaccination outweigh the long-term risks? A decision-analytic model for policymakers and pediatricians  Clin.Infect.Dis.  4-1-2002, 34 (7): 885-894.

  46. Silvers, L. E., Varricchio, F. E., Ellenberg, S. S., Krueger, C. L., Wise, R. P., and Salive, M. E.  Pediatric deaths reported after vaccination: the utility of information obtained from parents  Am.J.Prev.Med.  2002, 22 (3): 170-176.

  47. Skull, S. A. and Butler, J. R.  Meningococcal vaccination for adolescents? An economic evaluation in Victoria  J.Paediatr.Child Health.  2001, 37 (5): S28-S33.

  48. Sparkes, A. H.  Towards a more rational and scientific approach to vaccination  J.Feline.Med.Surg.  2001, 3 (2): 45-46.

  49. St, S., Jacobson, R. M., Vierkant, R. A., Jacobsen, S. J., Green, E. M., and Poland, G. A.  Association of parental vaccination reports with measles, mumps, and rubella protective antibody levels: comparison of Somali immigrant, Hispanic migrant, and US children in Rochester, Minn  Mayo Clin.Proc.  2002, 77 (3): 241-245.

  50. Stevenson, J., Massoudi, M., Stokley, S., and Bulim, I.  Clinical assessment software application (CASA) and immunization coverage rates  Am.J.Public Health.  2002, 92 (3): 333-334.

  51. Stevenson, M., Beard, S., Finn, A., and Brennan, A.  Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule  Vaccine.  3-15-2002, 20 (13): 1778-1786.

  52. Tschantz, K. and Foley, L. A.  Lifesaving opportunities missed: the challenge of vaccinating older Americans for pneumococcal diseases and influenza  Issue.Brief.(Public Policy Inst.(Am.Assoc.Retired.Pers.)).  2000, IB45): 1-9.

  53. van den, Hof S., Wallinga, J., Widdowson, M. A., and Conyn-van Spaendonck, M. A. E.  Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules  Epidemiol.Infect.  2001, 128 (1): 47-57.

  54. Wettendorff, M.  Therapeutic vaccination  Virus Res.  1-30-2002, 82 (1-2): 133-140.

  55. Wiesen, A. R. and Littell, C. T.  Relationship Between Prepregnancy Anthrax Vaccination and Pregnancy and Birth Outcomes Among US Army Women  JAMA.  3-27-2002, 287 (12): 1556-1560.

[top]